Life360 director exercises options and sells 7,930 shares

Rhea-AI Filing Summary

Life360, Inc. director Charles J. Prober exercised stock options for 7,930 shares of common stock at an exercise price of $11.18 per share on February 13, 2026, then sold 7,930 shares in open-market transactions at an average price of $49.02 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025. Following these transactions, he directly holds 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and retains 71,370 stock options subject to the vesting schedule described.

Insider Trade Summary

Exercise and Sale: 7,930 shares ($300K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Prober Charles J.

Role Director

Sold 7,930 shs ($389K)

Approx. gross sale proceeds $389K

Approx. exercise cost $89K

Approx. pre-tax spread $300K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	7,930	$0.00	$0.00
Exercise	Common stock	7,930	$11.18	$89K
Sale	Common stock	7,930	$49.02	$389K

Holdings After Transaction: Stock Option (right to buy) — 71,370 contracts (Direct); Common stock — 105,456 shares (Direct)

Footnotes (3)

1. F1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
2. F2. Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
3. F3. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Life360 (LIF) director Charles Prober do in this Form 4?

Charles J. Prober exercised stock options for 7,930 Life360 shares, then sold 7,930 shares in open-market trades. These actions were executed on February 13, 2026 under a pre-established Rule 10b5-1 trading plan with predetermined criteria for automatic stock sales.

How many Life360 (LIF) shares did Charles Prober sell and at what price?

Charles Prober sold 7,930 shares of Life360 common stock at an average price of $49.02 per share. The sale occurred on February 13, 2026 and was reported as an open-market or private transaction coded as an “S” sale on the Form 4.

What stock options did Charles Prober exercise in Life360 (LIF)?

He exercised stock options covering 7,930 shares of Life360 common stock at an exercise price of $11.18 per share. These options are part of a grant that vests half on April 1, 2024, with the remaining portion vesting in equal monthly installments over 24 months.

How many Life360 (LIF) shares does Charles Prober hold after these transactions?

After the reported trades, Charles Prober directly owns 105,456 shares of Life360 common stock. This total includes 1,357 restricted stock units, each representing a contingent right to receive one share of common stock when the applicable vesting conditions are satisfied.

Was the Life360 (LIF) stock sale by Charles Prober under a Rule 10b5-1 plan?

Yes. The transaction was executed under a Rule 10b5-1 trading plan adopted on March 14, 2025. This written, pre-established plan provides for automatic stock sales using predetermined criteria, and was put in place when he was not aware of material nonpublic information.

What is the vesting schedule of Charles Prober’s Life360 (LIF) stock options?

The option vests 50% of the total shares on April 1, 2024. The remaining shares vest in 1/24th monthly installments until fully vested, subject to Charles Prober’s continued service with Life360 on each applicable vesting date described in the award terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:18 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prober Charles J.

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	02/13/2026		M(1)		7,930	A	$11.18	113,386(2)	D
Common stock	02/13/2026		S(1)		7,930	D	$49.02	105,456(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$11.18	02/13/2026		M(1)			7,930	(3)	04/12/2028	Common stock	7,930	$0	71,370	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Remarks:

	/s/ Jay Sood, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.